Skip to main content
SpringerLink
Log in

Increased circulating level of CTRP15 in patients with type 2 diabetes mellitus and its relation with inflammation and insulin resistance

  • Research article
  • Published:
Journal of Diabetes & Metabolic Disorders Aims and scope Submit manuscript

Abstract

Aims

Type 2 diabetes mellitus (T2DM) is a highly prevalence disease that has a close relation with secretory factors such as adipokines and myokines. C1q tumor necrosis factor-α (TNF-α)-related protein 15 (CTRP15) is a paralogue paralogue of adiponectin that has a close relation with insulin resistance and inflammation. The present study aimed to assess circulating levels of CTRP15 in patients with T2DM in comparison with controls and thier association with inflammatory cytokines.

Methods

This case–control study was performed on 80 T2DM patients and 80 controls which diagnosed according to the criteria of American Diabetes Association (ADA). Serum levels of CTRP15, adiponectin, TNF-α, and interleukin- 6 (IL-6) were determined using ELISA kits.

Results

The results indicated higher concentration of CTRP15 in T2DM patients (103.17 ± 27.99) compared to the controls (66.11 ± 20.46, p < 0.001), while adiponectin decreased considerably in the patients compared to the controls (p < 0.001). Moreover, circulating levels of IL-6 and TNF-α elevated in the patients compared to the controls (p < 0.001). CTRP15 indicated independent association with BMI and adiponectin in the controls while, in the patients it demonstrated independent association with HOMA-IR and TNF-α.

Conclusions

Higher concentration of CTRP15 in the patients and its relation with insulin resistance and inflammation suggested a relation of CTRP15 with the pathogenesis of diabetes. In addition, it seems likely that patients with T2DM had a CTRP15 resistance; however, future studies are necessary to prove this concept.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

Data Availability

The data generated during and/or analyzed during the current study are available from the corresponding authors [N Z] on reasonable request. The data are not publicly available due to [restrictions e.g. containing information that could compromise the privacy of research participants].

References

  1. Emerging Risk Factors Collaboration, Sarwar N, Gao P, Seshasai SR, Gobin R, Kaptoge S, Di Angelantonio E, et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet. 2010;375(9733):2215–22. https://doi.org/10.1016/S0140-6736(10)60484-9.

  2. Khunti K, Alsifri S, Aronson R, CigrovskiBerković M, Enters-Weijnen C, Forsén T, et al. Rates and predictors of hypoglycaemia in 27 585 people from 24 countries with insulin-treated type 1 and type 2 diabetes: the global HAT study. Diabetes Obes Metab. 2016;18(9):907–15.

    Article  CAS  Google Scholar 

  3. Ogurtsova K, da Rocha Fernandes JD, Huang Y, Linnenkamp U, Guariguata L, Cho NH, et al. IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res Clin Pract. 2017;128:40–50.

    Article  CAS  Google Scholar 

  4. Lee M-K, Han K, Kim MK, Koh ES, Kim ES, Nam GE, et al. Changes in metabolic syndrome and its components and the risk of type 2 diabetes: a nationwide cohort study. Sci Rep. 2020;10(1):2313.

    Article  CAS  Google Scholar 

  5. Hajer GR, van Haeften TW, Visseren FLJ. Adipose tissue dysfunction in obesity, diabetes, and vascular diseases. Eur Heart J. 2008;29(24):2959–71.

    Article  CAS  Google Scholar 

  6. Zatterale F, Longo M, Naderi J, Raciti GA, Desiderio A, Miele C, et al. Chronic Adipose Tissue Inflammation Linking Obesity to Insulin Resistance and Type 2 Diabetes. Front Physiol. 2020;10:1607.

    Article  Google Scholar 

  7. Ellulu MS, Patimah I, Khaza’ai H, Rahmat A, Abed Y. Obesity and inflammation: the linking mechanism and the complications. Arch Med Sci. 2017;13(4):851–63.

    Article  CAS  Google Scholar 

  8. Burhans MS, Hagman DK, Kuzma JN, Schmidt KA, Kratz M. Contribution of Adipose Tissue Inflammation to the Development of Type 2 Diabetes Mellitus. Compr Physiol. 2018;9(1):1–58.

    PubMed  PubMed Central  Google Scholar 

  9. Czech MP. Insulin action and resistance in obesity and type 2 diabetes. Nat Med. 2017;23(7):804–14.

    Article  CAS  Google Scholar 

  10. Kershaw EE, Flier JS. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab. 2004;89(6):2548–56.

    Article  CAS  Google Scholar 

  11. Dıez JJ, Iglesias P. The role of the novel adipocyte-derived hormone adiponectin in human disease. Eur J Endocrinol. 2003;148(3):293–300.

    Article  Google Scholar 

  12. Davis KE, Scherer PE. Adiponectin: no longer the lone soul in the fight against insulin resistance? Biochemical Journal. 2008;416(2):e7–9.

    Article  CAS  Google Scholar 

  13. Fadaei R, Moradi N, Baratchian M, Aghajani H, Malek M, Fazaeli AA, et al. Association of C1q/TNF-related protein-3 (CTRP3) and CTRP13 serum levels with coronary artery disease in subjects with and without type 2 diabetes mellitus. PloS one. 2016;11(12):e0168773.

    Article  Google Scholar 

  14. Seldin MM, Tan SY, Wong GW. Metabolic function of the CTRP family of hormones. Rev Endocr Metab Disord. 2014;15(2):111–23.

    Article  CAS  Google Scholar 

  15. Thiriet M. Hyperlipidemias and Obesity. In: Thiriet M, editor. Vasculopathies: Behavioral, Chemical, Environmental, and Genetic Factors. Cham: Springer International Publishing; 2018. p. 331–548.

    Chapter  Google Scholar 

  16. Seldin MM, Peterson JM, Byerly MS, Wei Z, Wong GW. Myonectin (CTRP15), a novel myokine that links skeletal muscle to systemic lipid homeostasis. J Biol Chem. 2012;287(15):11968–80.

    Article  CAS  Google Scholar 

  17. Gamas L, Matafome P, Seiça R. Irisin and Myonectin Regulation in the Insulin Resistant Muscle: Implications to Adipose Tissue: Muscle Crosstalk. J Diab Res. 2015;2015:359159.

    Google Scholar 

  18. Little HC, Rodriguez S, Lei X, Tan SY, Stewart AN, Sahagun A, et al. Myonectin deletion promotes adipose fat storage and reduces liver steatosis. FASEB J. 2019;33(7):8666–87.

    Article  CAS  Google Scholar 

  19. Shokoohi Nahrkhalaji A, Ahmadi R, Fadaei R, Panahi G, Razzaghi M, Fallah S. Higher serum level of CTRP15 in patients with coronary artery disease is associated with disease severity, body mass index and insulin resistance. Arch Physiol Biochem. 2019:1–5.

  20. Otaka N, Shibata R, Ohashi K, Uemura Y, Kambara T, Enomoto T, et al. Myonectin Is an Exercise-Induced Myokine That Protects the Heart From Ischemia-Reperfusion Injury. Circ Res. 2018;123(12):1326–38.

    Article  CAS  Google Scholar 

  21. Mi Q, Li Y, Wang M, Yang G, Zhao X, Liu H, et al. Circulating C1q/TNF-related protein isoform 15 is a marker for the presence of metabolic syndrome. Diab/Metabol Res Rev. 2019;35(1):e3085.

    Article  Google Scholar 

  22. Han S, Kim JD, Lee S, Jeong AL, Park JS, Yong HJ, et al. Circulating CTRP1 levels in type 2 diabetes and their association with FGF21. Int J Endocrinol. 2016;2016.

  23. Moradi N, Fadaei R, Khamseh ME, Nobakht A, Rezaei MJ, Aliakbary F, et al. Serum levels of CTRP3 in diabetic nephropathy and its relationship with insulin resistance and kidney function. Plos One. 2019;14(4):e0215617.

    Article  CAS  Google Scholar 

  24. Gorgani-Firuzjaee S, Khodabandehloo H. Circulating Levels of C1q/TNF-Related Protein-12 (CTRP-12) in Patients with Type 2 Diabetes: A Case-control Study. J Kerman Univ Med Sci. 2020;27(3):262–9.

    Google Scholar 

  25. Li K, Liao X, Wang K, Mi Q, Zhang T, Jia Y, et al. Myonectin predicts the development of type 2 diabetes. J Clin Endocrinol Metab. 2018;103(1):139–47. https://doi.org/10.1210/jc.2017-01604.

  26. Mi Q, Li Y, Wang M, Yang G, Zhao X, Liu H, et al. Circulating C1q/TNF-related protein isoform 15 is a marker for the presence of metabolic syndrome. Diab/Metabol Res Rev. 2019;35(1):e3085.

    Article  Google Scholar 

  27. Toloza FJK, Mantilla-Rivas JO, Pérez-Matos MC, Ricardo-Silgado ML, Morales-Alvarez MC, Pinzón-Cortés JA, et al. Plasma Levels of Myonectin But Not Myostatin or Fibroblast-Derived Growth Factor 21 Are Associated with Insulin Resistance in Adult Humans without Diabetes Mellitus. Front Endocrinol. 2018;9(5).

  28. Zhang J, Chen L, Ye J. Correlation analysis of myonectin levels with metabolic and hormonal disorders in patients with polycystic ovary syndrome. Ann Palliat Med. 2021;10(3):3404–9. https://doi.org/10.21037/apm-21-458.

  29. Sharma N, Castorena CM, Cartee GD. Greater insulin sensitivity in calorie restricted rats occurs with unaltered circulating levels of several important myokines and cytokines. Nutr Metab (Lond). 2012;9(1):90.

    Article  CAS  Google Scholar 

  30. Wang C, Luo Y, Qiu L, Li X, Huang Q, Chen X. Association of serum myonectin concentrations with the presence of atrial fibrillation. 2021.

Download references

Funding

The study was funded by Vice-chancellor for Research and Technology, Hamadan University of Medical Sciences (No. 9609075587).

Author information

Author notes

  1. Samaneh Mohassel Azadi and Hossein Shateri contributed equally to this work.

Authors and Affiliations

  1. Department of Clinical Biochemistry, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran

    Samaneh Mohassel Azadi

  2. Department of Clinical Biochemistry, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran

    Hossein Shateri, Mohammad Mohammadi & Nasrin Ziamajidi

  3. Sleep Disorders Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran

    Reza Fadaei

  4. Department of Internal Medicine, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran

    Firozeh Sajedi

  5. Molecular Medicine Research Center, Hamadan University of Medical Sciences, Hamadan, Iran

    Nasrin Ziamajidi

Authors
  1. Samaneh Mohassel Azadi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hossein Shateri
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mohammad Mohammadi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Reza Fadaei
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Firozeh Sajedi
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Nasrin Ziamajidi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nasrin Ziamajidi.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mohassel Azadi, S., Shateri, H., Mohammadi, M. et al. Increased circulating level of CTRP15 in patients with type 2 diabetes mellitus and its relation with inflammation and insulin resistance. J Diabetes Metab Disord 20, 1499–1504 (2021). https://doi.org/10.1007/s40200-021-00892-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40200-021-00892-2

Keywords

Search

Navigation